Skip to main content

Solriamfetol News

Solriamfetol Effective for Managing ADHD in Adults

TUESDAY, Oct. 17, 2023 – Solriamfetol seems to be effective for management of attention-deficit/hyperactivity disorder (ADHD) in adults, according to a study published online Oct. 9 in the Journal...

Narcolepsy Drug, Solriamfetol, Might Be New Treatment Option for ADHD

WEDNESDAY, Oct. 11, 2023 – A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief f...

FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

DUBLIN, March 20, 2019 /PRNewswire/ – Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome

Solriamfetol patient information at Drugs.com